Ceredex Value Advisors Acquires Stake in CME Group

Hedge fund purchases 57,600 shares of financial services provider

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Ceredex Value Advisors LLC, a hedge fund, has purchased a new stake of 57,600 shares in CME Group Inc. (NASDAQ:CME), a leading global financial derivatives exchange, according to a recent 13F filing with the SEC. The stake is valued at approximately $15.6 million.

Why it matters

This investment by Ceredex Value Advisors in CME Group reflects the hedge fund's confidence in the financial services provider's growth potential. As one of the world's largest derivatives exchanges, CME Group's performance is closely watched by investors and analysts as an indicator of broader market trends.

The details

Ceredex Value Advisors LLC, an investment management firm, disclosed the new stake in CME Group in its latest 13F filing with the Securities and Exchange Commission. The 57,600 shares purchased represent a new position for the hedge fund in the financial services provider.

  • Ceredex Value Advisors LLC acquired the stake in CME Group during the third quarter of the year.

The players

Ceredex Value Advisors LLC

An investment management firm that has purchased a new stake in CME Group Inc.

CME Group Inc.

A leading global financial derivatives exchange that operates exchanges including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX.

Got photos? Submit your photos here. ›

The takeaway

Ceredex Value Advisors' investment in CME Group signals the hedge fund's belief in the exchange operator's continued growth and success in the global financial markets. As a major player in the derivatives space, CME Group's performance is closely watched as an indicator of broader market trends.